Health & Fitness:Medicine
Despite current standard care for glioblastoma being aggressive, mean survival is around 14 months. Clark Chen (director of Clinical Neuro-oncology, Beth Israel Deaconess Medical Center, Boston) argues we need a better understanding of the therapeutic concepts that have evolved over the past three decades to develop treatment, and in a JNNP article this month he lays out seven of these key ideas. Peter Warnke (JNNP associate editor) discusses them with him.
See also:
Key concepts in glioblastoma therapy http://tinyurl.com/ao8g8m3
More Episodes
Vestibular neurology for the generalist
2025-06-16
1.3k
2025-06-16
1.3k
Cyclophosphamide for myasthenia gravis: a comeback?
2025-04-17
1.2k
2025-04-17
1.2k
Management methods for acute ischaemic stroke
2025-02-13
1.5k
2025-02-13
1.5k
Nutritional peripheral neuropathies, with Dr. Alexander Rossor
2024-04-17
2.0k
2024-04-17
2.0k
Distinguishing primary from functional tics
2024-02-19
2.0k
2024-02-19
2.0k
Nitrous Oxide Abuse
2023-09-22
2.3k
2023-09-22
2.3k
Brain Fog Demystified
2023-08-08
2.7k
2023-08-08
2.7k
A roadmap to ALS prevention: strategies and priorities
2023-06-15
2.3k
2023-06-15
2.3k
MOGAD: Definition, diagnosis and treatment
2023-05-15
1.8k
2023-05-15
1.8k
Cerebral Microbleeds: from depiction to interpretation
2021-07-05
391
2021-07-05
391
Motor functional neurological disease, a decade of progress
2021-06-25
359
2021-06-25
359
Drug repurposing for progressive multiple sclerosis
2021-03-02
247
2021-03-02
247
Get this podcast on your
phone, FREE
